5.9× net-debt/EBITDA into a "higher-for-longer" rate world — interest expense already eats ~38% of EBIT
One-line thesis. TransDigm is a genuinely elite business — a "public private-equity firm" that buys sole-source, proprietary aerospace aftermarket parts and raises prices for decades — but the stock is up against a full 42× multiple, a stretched RSI, a heavy 5.9× debt load, and 12-month price underperformance (−11% vs SPY +21%). Great company, unexciting entry: Watch.
◆ Synthos call — HoldTDG is a solid business largely reflected at ~$1,360 — fine to keep, no reason to chase; it gets interesting again below ~$1,156.
Real compounder, but M&A-fuelled and decelerating; $75B cap and mature niche cap the multibagger.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 33%/yrTo justify today’s $1,348, earnings would have to compound roughly 33% a year for 10 years (9% discount rate). Analysts forecast ~15%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
TransDigm makes small, boring, mission-critical airplane parts — latches, pumps, actuators, ignition systems — where it is very often the only approved supplier. Once a part is designed into a jet that flies for 30 years, the airline has to keep buying replacements from TransDigm, and TransDigm raises the price every year. That is a fantastic, cash-gushing business model, run like a buyout shop that keeps borrowing money to buy more of these little monopolies.
The catch: the stock is expensive (you pay about $42 for every $1 of annual profit), the company owes a lot of money (roughly six years of earnings-before-interest in debt), and the shares have actually gone nowhere for a year while the rest of the market climbed. Our verdict is Watch — admire the business, wait for a better price.
Here's what our three scores mean in everyday terms:
Downside Risk 6/10 (a bit above average). The business itself is recession-resistant and the stock is not jumpy, but the mountain of debt and the high price tag mean a stumble would hurt.
Growth Quality 8/10 (very good). Steady mid-teens profit growth, huge margins, and a moat that is hard to attack.
Exponential Potential 4/10 (modest). It grows nicely by buying companies, but it's already big and slowing down — don't expect it to double fast.
The one big worry: TransDigm's whole strategy runs on cheap debt. Its interest bill already swallows over a third of operating profit, so if rates stay high for years, the machine grinds slower.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = TDG · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$1,348.49
Market cap$75B
P/E trailing59×
P/E FY26E / FY27E34× / 29×
EV / Sales10.9×
EV / EBITDA21.6×
Gross margin59.0%
Net margin21.3%
Dividend yield12.24%
Beta0.895
52-wk range$1,133 – $1,621
RSI(14)70
50 / 200-DMA$1,233 / $1,284
12-mo return+-11% (SPY +21%)
Street target$1,569 ($1,350–$1,871)
Analyst grades22 Buy · 17 Hold · 0 Sell
FMP ratingC+
Next earnings2026-08-05
What the experts actually said 2 traceable claims on TDG · showing the highest-conviction voices
“TransDigm is a buy: a public private-equity firm acquiring niche proprietary aerospace parts with immense, expanding pricing power/margins.”
Invest Like the Bestbullishconviction 652026-05-29invest_like_the_best-wz-nbqJGzGo:41f5b4f42f
“TransDigm is in a slower cyclical patch—acquisition debt taken at 2022-era higher rates makes it sensitive to a higher-rate environment.”
Invest Like the Bestneutralconviction 552026-05-29invest_like_the_best-wz-nbqJGzGo:66934fede6
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
TransDigm Group (NYSE: TDG) is a Cleveland-based aerospace components maker, founded 1993, that operates less like a manufacturer and more like a disciplined private-equity roll-up. Its edge is a portfolio of highly engineered, proprietary, sole-source parts — roughly ~90% proprietary and a large majority sole-source — sold heavily into the commercial aftermarket, where recurring, price-insensitive replacement demand supports decades of above-inflation price increases. Fiscal year ends late September.
Revenue mix (FY2025, from filings):
By segment: Power & Control $4,559M (52%) · Airframe $4,112M (47%) · Non-Aviation $160M (2%). The two aviation segments are the whole story; the non-aviation stub is immaterial.
By geography: United States $5,535M (63%) · Non-US $3,296M (37%). US-weighted but with meaningful global airline exposure.
By end market (management commentary, §9): the business splits across commercial aftermarket (the crown jewel — highest-margin, recurring), commercial OEM, and defense. In FQ2'26 the commercial aftermarket led growth, with commercial transport aftermarket +16%.
The model: acquire niche proprietary-part makers, apply the "value drivers" (pricing, new business, productivity), fund it with debt, and periodically return capital via special dividends or buybacks. It has compounded revenue from ~$5.1B (FY20) to $8.83B (FY25) — much of it via M&A.
2. The expert thesis — thin coverage, so this is a quant/fundamentals call (traceable)
Honest disclosure up front: the Synthos KB has only 2 claims on TDG from 1 source (Invest Like the Best), net 1 bullish voice. This is not a high-breadth conviction name like our flagship healthcare positions. The verdict below is therefore fundamentals- and quant-driven, with the expert claims used only as corroboration, not as an anchor.
The bull frame (traceable). Invest Like the Best (invest_like_the_best-wz-nbqJGzGo:41f5b4f42f, bullish, conviction 65) frames TDG as "a public private-equity firm acquiring niche proprietary aerospace parts with immense, expanding pricing power/margins." That is the correct mental model and it is borne out in the numbers (59% gross margin, 50%+ EBITDA-as-defined margin).
The cautionary frame — from the same source (traceable). Invest Like the Best (invest_like_the_best-wz-nbqJGzGo:66934fede6, neutral, conviction 55): TDG "is in a slower cyclical patch — acquisition debt taken at 2022-era higher rates makes it sensitive to a higher-rate environment." This is the crux of our own caution: the leverage that supercharges returns in a low-rate world is a headwind now (see §5, §11).
Honest composite note. With a single voice on both sides of the ledger, there is no panel consensus to lean on. We treat the business quality as real and well-documented, but the stock call rests on valuation, leverage, and price action — where the picture is far less compelling than the franchise.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
6 · Above-average
Low beta (0.90) and a recession-resistant aftermarket cushion the downside, but 5.9× net-debt/EBITDA, negative book equity (from special dividends), 42× trailing EPS, and interest eating ~38% of EBIT stack real financial risk.
Growth Quality
8 · High
~16% forward EPS CAGR, 59% gross / 50%+ EBITDA margin, ROIC ~14.5% well above cost of capital, and a genuinely durable sole-source moat. Docked from 9 because much of the growth is bought, not organic (organic sales +9–11%).
Exponential Potential
4 · Modest
A superb compounder, but a decelerating, M&A-fuelled one in a mature niche. Revenue growth is easing from the post-COVID recovery pace, and a $75B cap in a finite parts market caps the multibagger.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
Estimates roughly hit — FY27E EPS ~$47; a durable mid-teens compounder with 50% EBITDA margin earns a ~29× multiple, in line with its own recent history.
~$1,360 (+1%)
Bear
Air-traffic/aftermarket softens, rate stays high and interest compounds, an acquisition disappoints. FY27E EPS misses to ~$42; multiple de-rates to ~23×.
~$960 (−29%)
Synthos fair value = the base case, ~$1,360 (+1%), with the full $960–$1,680 span as the honest range. Our base sits well below the Street's $1,569 consensus: the sell side extrapolates the multiple and the M&A engine more generously than we will at 5.9× leverage into a higher-for-longer rate backdrop. Notably the Street's low target ($1,350) is essentially today's price — the whole sell-side range is skewed upward. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). TDG is a best-in-class compounder that is not accelerating:
Forward growth: revenue CAGR FY25→FY30E ~9% ($8.83B → $13.6B est); EPS CAGR ~16% ($32.08 GAAP FY25 → $68.13 est FY30) as pricing and buybacks lever earnings faster than sales.
Acceleration (the 2nd derivative) is negative: the post-COVID aftermarket snap-back (revenue +18% FY24, similar early-FY26) fades toward high-single-digit organic growth; consensus revenue growth eases from ~+18% (FY25) toward ~+7% (FY30E). The steep part of the recovery is behind it.
Room to run: the proprietary-aerospace-parts niche is lucrative but finite — this is not a $100B+ new-category TAM. At $75B market cap, further multibagging depends on continued debt-funded M&A rather than an organic secular wave.
Reinvestment runway: the real engine is capital allocation — acquisitions ($419M FY25, plus $2.2B Jet Parts/Victor Sierra and ~$960M Stellant post-quarter) and buybacks (~$905M FYTD). Productive, but debt-financed, so it lives and dies on the cost of capital.
Exponential Potential: Modest (4/10). Own TDG for durable mid-teens earnings compounding and elite capital allocation — not for a fast multibagger. The very leverage that has powered the historical multibagger is now a governor.
Revenue: FY25 $8.83B, +11.2% (FY24 $7.94B, +20.5% on FY23 $6.59B). Steady double-digit growth, part organic (aftermarket pricing/volume), part M&A.
Quarterly trajectory: FQ1'26 $2.29B → FQ2'26 $2.54B (+18.3% YoY); FQ2 organic growth 11.0%. Momentum intact through the latest print.
Margins (elite): gross 59.0% TTM, EBITDA 50.3% TTM (EBITDA-As-Defined 52.6% in FQ2'26 per management), operating ~46.5%. Among the best in all of industrials.
Earnings: GAAP net income $2.07B FY25 (EPS $32.08); FQ2'26 net income $536M, EPS $9.20, adjusted EPS $9.85. Consensus GAAP EPS builds to $40 (FY26E) → $47 (FY27E) → $68 (FY30E).
Cash flow: FY25 operating CF $2.04B, capex only ~−$222M (asset-light) → FCF ~$1.82B. High FCF conversion is the model's oxygen — it services the debt and funds deals/dividends.
Balance sheet — the flag: total debt $30.0B, net debt $27.2B, net-debt/EBITDA 5.9×. Book equity is negative (−$9.7B) — a feature of returning cash via huge special dividends (FY25 dividends paid $9.6B), not distress, but it means conventional P/B and ROE are meaningless. Interest expense $1.57B FY25 consumes ~38% of EBIT; interest coverage ~2.5×. Serviceable given fat FCF, but it is the single biggest structural risk.
6. Valuation — priced in or room?
TDG is not cheap on any trailing metric (42× EPS, 10.9× sales, 21.6× EV/EBITDA). The bull's defense is the same as for any quality compounder: earnings grow into the multiple — forward P/E compresses to 34× (FY26E) → 29× (FY27E) → 20× (FY30E) if estimates hit. But two things temper that:
1. EV/EBITDA is the honest lens here given the leverage — and at 21.6× TTM, TDG is already at the rich end of its own history, so the multiple offers little cushion.
2. The stock has de-rated in price terms already — −11% over 12 months while earnings grew — which tells you the market has been paying down the premium, not expanding it.
Our ~$1,360 base fair value (+1%) says the shares are roughly fairly priced for a great business — attractive to hold, unexciting to initiate. Street targets (context): consensus $1,569, high $1,871, low $1,350 — we are deliberately below the Street because we underwrite the leverage and rate sensitivity more conservatively. Not a value buy, and — unlike a true compounder-at-a-discount — not obviously a growth buy at today's price either.
7. Technicals (from the tech block)
Trend:mixed. $1,348 sits above the 50-DMA ($1,233) but below the 200-DMA ($1,284) — a recovering short-term trend inside a flat-to-down longer-term one. MACD +28.6 (positive, near-term).
Location:−16.8% off the 52-week high ($1,621) and +19% off the 52-week low ($1,133) — mid-range, with a −16.8% max drawdown from peak. Not a breakout name.
Momentum: RSI(14) 70.4 — right at the overbought threshold. After a +15% 3-month bounce, the entry is stretched, not fresh.
Relative strength (the tell): TDG −10.9% 12-mo vs SPY +20.6% and QQQ +30.3% — a full year of underperformance. It has kept pace over 3 months (+14.9% vs SPY +13.7%) but lags badly over 6–12 months.
Read: technicals do not confirm an aggressive buy. A stretched RSI after a bounce, below the 200-DMA, and 12-month underperformance argue for patience — wait for a pullback toward the 50-DMA (~$1,233) or lower.
8. Moat & competitive position
TDG's moat is unusually clean: sole-source, proprietary parts designed into aircraft that fly for decades, sold into a fragmented aftermarket where the airline has no approved alternative and switching means re-certification. That yields pricing power few industrials can match — the source of the 59% gross / 50%+ EBITDA margins. The durable risks are (a) OEM/regulator pushback on aftermarket pricing (a perennial political target), (b) the air-traffic cycle (aftermarket demand tracks flight hours), and (c) the leverage that funds the strategy. The moat is real; the stock's risk is financial and valuation, not competitive displacement.
Peer set (FMP-provided, market cap): General Dynamics $101B, Quanta $100B, Vertiv $115B, Johnson Controls $86B, Emerson $78B, Northrop Grumman $78B, Illinois Tool Works $78B, Cintas $73B, L3Harris $56B, Thomson Reuters $39B. Note: FMP's peer list is a broad industrials/A&D basket, not a like-for-like aftermarket comp — TDG's true comps are Heico and the aftermarket units of the majors. TDG commands a premium multiple within the group, justified by its margin profile and aftermarket mix.
9. Management, capital allocation & guidance
Capital allocation (the core competency): a disciplined, debt-funded acquire-and-optimize machine. FY25 deployed $419M on acquisitions; post-FQ2'26 closed Jet Parts Engineering + Victor Sierra ($2.2B) and agreed Stellant Systems (~$960M); repurchased ~$905M of stock FYTD; historically pays large special dividends (FY25 dividends paid $9.6B). ROIC ~14.5% clears the cost of capital — the M&A creates value if debt stays affordable.
Insider activity: the most recent Form 4 cluster (filed 2026-06-22/24) shows founder/chairman W. Nicholas Howley exercising options (10,132 shares at $66.47) and selling ~3,060 shares into the $1,305–$1,316 range — an option-exercise-and-sell, routine for a long-tenured insider at these prices, not a red-flag discretionary dump. No alarming cluster in the sampled window.
Management's own guidance (the earnings-call track — half-weighted; they talk their book): the SEC 8-K (FQ2'26, filed 2026-05-05) contains a real, substantive earnings release with an explicit raised outlook. CEO Mike Lisman: TransDigm raised full-year fiscal-2026 guidance, increasing the midpoint for sales by ~$420M, EBITDA-As-Defined by ~$210M, and adjusted EPS by ~$1.14, "the large majority… coming from stronger than expected performance in our base business," with the balance from the Jet Parts/Victor Sierra acquisition. Reported FQ2'26: sales $2,544M (+18%), EBITDA-As-Defined margin 52.6%, adjusted EPS $9.85 (+8%). Half-weighted as management's own self-interested words, but it is a genuine, positive guidance raise, not boilerplate.
10. Catalysts & what to watch
Next earnings: 2026-08-04 (FQ3'26; Street EPS $10.26, revenue ~$2.67B). Key lines: commercial aftermarket organic growth and EBITDA-As-Defined margin (watch for acquisition dilution).
Aftermarket / air-traffic trend: revenue passenger miles and airline flight hours drive the highest-margin revenue — the single biggest fundamental swing factor.
M&A cadence and price paid: integration of Jet Parts/Victor Sierra and closing of Stellant; multiples paid signal capital-allocation discipline.
Rates & refinancing: the cost of new/refinanced debt (recent issues at 6.125%) directly gates the model — falling rates are a tailwind, higher-for-longer a headwind.
Special dividend: TDG periodically returns cash via large special dividends; a declaration is a capital-allocation catalyst.
Thesis tripwires (what would change the call): two quarters of organic aftermarket deceleration; EBITDA-As-Defined margin slipping below ~50%; interest coverage falling toward ~2×; or an out-of-pattern, richly priced acquisition.
11. Key risks
Leverage / rate sensitivity (structural — and expert-flagged): 5.9× net-debt/EBITDA, ~38% of EBIT to interest, negative book equity. Invest Like the Best (invest_like_the_best-wz-nbqJGzGo:66934fede6) flags exactly this — "acquisition debt taken at 2022-era higher rates makes it sensitive to a higher-rate environment."
Valuation / de-rating: 42× trailing, 21.6× EV/EBITDA at the rich end of history leaves little room for a demand or margin disappointment.
Cyclicality: aftermarket demand tracks the air-traffic cycle; a travel downturn hits the highest-margin revenue.
Aftermarket-pricing scrutiny: TDG's pricing power is a recurring political/regulatory target (past DoD IG scrutiny); a policy shift could compress the moat's economics.
M&A dependence: growth relies on a steady pipeline of accretive deals at sane prices — a scarcer, pricier deal environment slows the engine.
Thin expert coverage: with only 2 KB claims, there is no broad independent panel corroborating (or challenging) the thesis — conviction rests on fundamentals.
12. Verdict, position sizing & monitoring
Watch. TransDigm is one of the highest-quality business models in the S&P 500 — sole-source aerospace parts, 59% gross / 50%+ EBITDA margins, elite capital allocation, and a management raising guidance on base-business strength. But as a stock at $1,348, the setup is unexciting: a full 42× / 21.6× EV/EBITDA multiple, 5.9× net leverage into a higher-for-longer rate world, a stretched 70 RSI after a bounce, price below the 200-DMA, and a full year of underperformance (−11% vs SPY +21%). Our base fair value (~$1,360) is essentially flat to spot, and our conservative underwriting of the leverage puts us well below the Street's $1,569. Great company, wait for a better price.
Sizing:Watch-list first. If initiated, treat as a satellite quality holding, ~1–3%, scaled in on weakness toward the 50-DMA (~$1,233) or lower — not a full-size initiation at a stretched RSI.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print, with special attention to organic aftermarket growth and interest coverage. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $1,348.49.
Single biggest risk: the debt. The strategy that made TDG a multibagger runs on cheap leverage; at 5.9× and ~38% of EBIT to interest, a higher-for-longer rate world is the governor on the whole machine.
Provenance & disclosures
Traceability: 2 KB claims, breadth 1 (Invest Like the Best), last claim 2026-05-29 — both reconciled to real claim_ids (cited inline). This is a thin-coverage name; the verdict is explicitly fundamentals/quant-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation).
Data as-of: fundamentals 2026-03-28 (FQ2'26) · estimates & prices 2026-07-02/03 · expert claims through 2026-05-29. Forward figures are analyst consensus (FMP), labeled as estimates.
Management caveat: the FQ2'26 8-K guidance raise is management's own book, half-weighted by design — but it is a genuine, substantive earnings release, not cover boilerplate.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").